Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in Primary Immune Thrombocytopenia
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab…
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab…
SATO Corporation, Interim report, 11th November, 2021 at 9:00 am Summary for 1 Jan–30 Sep 2021…
Third quarter 2021 net sales were $49.2 million, a decrease of 6.8% (or 7.1% on…
WILLIAMSBURG, Va., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or…
Press ReleaseOutside trading hours - Regulated information* Brussels, 12 November 2021 (07.00 a.m. CET) …
IRVINE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or…
MINNEAPOLIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- SharpLink Gaming Ltd. (Nasdaq:SBET) (“SharpLink” or the “Company”),…
New York, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video…
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Zai Lab…
Africa Mobile Networks (AMN) deploys hubs and places additional orders of Gilat cellular backhaul terminals to…